Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation
- PMID: 8386265
- PMCID: PMC237571
- DOI: 10.1128/JVI.67.5.2521-2528.1993
Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation
Abstract
The transforming function of human papillomavirus type 16 (HPV16) E7 has been shown to depend on activities additional to the ability to bind RB. In this paper we describe two further properties of E7 which may also contribute to transformation, an association with a histone H1 kinase at the G2/M phase of the cell cycle and an ability to bind the RB-related protein p107. The region of E7 identified previously as important for RB binding was found to be involved in the association with the kinase and complex formation with p107, although analysis of E7 point mutants within this region revealed a difference in the precise sequence requirement for RB and p107 binding. Association with the kinase activity correlated with the ability to bind RB, but the restriction of the kinase association to the G2/M phase of the cell cycle implies that this activity might not be directly mediated by RB binding. Since kinase-binding-deficient E7 mutants are also transformation defective, this may represent an independent function of E7 which plays a role in the G2/M phase of the cell cycle.
Similar articles
-
Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.J Virol. 2001 Aug;75(15):6737-47. doi: 10.1128/JVI.75.15.6737-6747.2001. J Virol. 2001. PMID: 11435552 Free PMC article.
-
Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107.Virology. 1996 Jan 1;215(1):73-82. doi: 10.1006/viro.1996.0008. Virology. 1996. PMID: 8553588
-
Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7.J Gen Virol. 1995 Jul;76 ( Pt 7):1815-20. doi: 10.1099/0022-1317-76-7-1815. J Gen Virol. 1995. PMID: 9049387
-
Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes.FASEB J. 1993 Jul;7(10):872-9. doi: 10.1096/fasebj.7.10.8393818. FASEB J. 1993. PMID: 8393818 Review.
-
The association of mammalian DREAM complex and HPV16 E7 proteins.Am J Cancer Res. 2015 Nov 15;5(12):3525-33. eCollection 2015. Am J Cancer Res. 2015. PMID: 26885443 Free PMC article. Review.
Cited by
-
Regulation of the human papillomavirus oncoproteins by differential phosphorylation.Mol Cell Biochem. 2001 Nov;227(1-2):137-44. Mol Cell Biochem. 2001. PMID: 11827165
-
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation.J Virol. 1996 Oct;70(10):6862-9. doi: 10.1128/JVI.70.10.6862-6869.1996. J Virol. 1996. PMID: 8794328 Free PMC article.
-
Synergism with germ line transcription factor Oct-4: viral oncoproteins share the ability to mimic a stem cell-specific activity.Mol Cell Biol. 1999 Apr;19(4):2635-43. doi: 10.1128/MCB.19.4.2635. Mol Cell Biol. 1999. PMID: 10082529 Free PMC article.
-
Human papilloma virus (HPV) and host cellular interactions.Pathol Oncol Res. 2008 Dec;14(4):345-54. doi: 10.1007/s12253-008-9056-6. Epub 2008 May 21. Pathol Oncol Res. 2008. PMID: 18493868 Review.
-
p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5320-4. doi: 10.1073/pnas.91.12.5320. Proc Natl Acad Sci U S A. 1994. PMID: 8202487 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources